SCHEMBL10312980

SCHEMBL10312980

COCc1ccc2c(n1)CN(C(C)=O)CC2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 2/20 0.46
HDAC1 Q13547 1/20 0.42
HDAC2 Q92769 1/20 0.42
HRH3 Q9Y5N1 2/20 0.39
GABRG2 P18507 3/20 0.38
GABRB3 P28472 3/20 0.38
GABRA5 P31644 3/20 0.38
KCNH2 Q12809 2/20 0.38
GRM5 P41594 1/20 0.36
ENPP2 Q13822 1/20 0.36
MAPK1 P28482 1/20 0.35
KDM4E B2RXH2 1/20 0.35
ESR2 Q92731 2/20 0.34
HTR2A P28223 1/20 0.34
HTR2C P28335 1/20 0.34
HTR2B P41595 1/20 0.34
F10 P00742 2/20 0.34
ESR1 P03372 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10312982 0.84 NOTUM (0.48) NOTUMHRH3GABRG2GABRB3GABRA5
SCHEMBL27137964 0.75 HDAC1 (0.48) HDAC1HDAC2GABRG2GABRB3GABRA5
SCHEMBL20738526 0.74 ESR2 (0.46) HDAC1HDAC2MAPK1ESR2
SCHEMBL10312978 0.73 NOTUM (0.55) NOTUMHRH3KDM4EESR2F10
SCHEMBL22982496 0.72 MAPK1 (0.35) NOTUMMAPK1KDM4EMEN1KMT2A
SCHEMBL29697592 0.71 ESR2 (0.54) GRM5MAPK1ESR2
SCHEMBL10313006 0.71 ESR2 (0.54) GRM5MAPK1ESR2
SCHEMBL29390598 0.71 ESR2 (0.54) GRM5MAPK1ESR2
SCHEMBL10313099 0.71 GRM5 (0.49) GRM5
SCHEMBL10312983 0.70 NOTUM (0.41) NOTUMHRH3GABRG2GABRB3GABRA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120178776-A1 DIHYDRONAPHTHYRIDINYL(ORGANO)METHANONE ANALOGS AS POSITIVE ALLOSTERIC MGLUR5 MODULATORS NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2012-07-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120178776-A1 DIHYDRONAPHTHYRIDINYL(ORGANO)METHANONE ANALOGS AS POSITIVE ALLOSTERIC MGLUR5 MODULATORS GRM5, GRIK5, GRM3 NOTUM 2863/4885HDAC1 2555/4885HDAC2 2291/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.